基本信息 | |
【中文】 盐酸乐卡地平 |
|
【英文名称】 75 CLAP mE10 c-E10 CIPER BCL10 CarMen LerzaM Zandip Lercan Zanicor Corifeo Renovia Vasodip Lercadip Lercapin Lercaton LerkaMen Cardiovasc BCL-10 human Lercaridipine LERCANIDIPINE HCL B-cell CLL/lymphoma 10 B-cell lymphoma/leukemia 10 LERCANIDIPINE HYDROCHLORIDE LERCANIDIPINEHYDROCHLORIDE(FORR&DONLY) Lercanidipine hydrochloride heMihydrate CARD-containing molecule enhancing NF-κ-B Lercanidipine hemihydrate hydrochloride 1,4-dihydro-2,6-diMethyl-4-(3-nitrophenyl)-3,5- 1,4-Dihydro-2,6-dimethyl-4-(3-nittrophenyl)-3,5-pyridinedicarboxylicAcid2-[(3,3-Diphenylpropyl)methylamino]-1,1-dimeth 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-[(3,3-diphenylpropyl)methylamino]-1,1-dimethylethyl methyl ester hydrochloride 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-[(3,3-diphenylpropyl)methylamino]-1,1-dimethylethyl methyl ester hydrochloride 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-2-[(3,3-diphenylpropyl)methylamino]-1,1-dimethylethyl methyl ester 3,5-pyridinedicarboxylic acid hydrochloride O3-[1-[3,3-diphenylpropyl(methyl)amino]-2-methyl-propan-2-yl] O5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride 1,4-Dihydro-2,6-dimethyl-4-(3-nittrophenyl)-3,5-pyridinedicarboxylic Acid 2-[(3,3-Diphenylpropyl)methylamino]-1,1-dimethylethyl Methyl Ester Hydrochloride 3-O-[1-[3,3-diphenylpropyl(methyl)amino]-2-methylpropan-2-yl] 5-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride 3,5-Pyridinedicarboxylicacid, 1,4-dihydro-2,6-diMethyl-4-(3-nitrophenyl)-,3-[2-[(3,3-diphenylpropyl)MethylaMino]-1,1-diMethylethyl] 5-Methyl ester,hydrochloride (1:1) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid O3-[2-[3,3-diphenylpropyl(methyl)amino]-1,1-dimethyl-ethyl] ester O5-methyl ester hydrochloride |
|
【CAS】 132866-11-6 |
|
【中文名称】 1,4-二氢-2,6-二甲基-4-(3-硝基苯基)-3,5-吡啶二羧酸 2-[(3,3-二苯丙基)甲基氨基]-1,1-二甲基乙基甲酯盐酸盐 盐酸乐卡地平 |
|
【分子式】 C36H42ClN3O6 |
|
【MDL 编号】 MFCD07773089 |
|
【分子量】 648.19 |
|
【MOL 文件】 132866-11-6.mol |
常见问题列表 | |
【概述】盐酸乐卡地平为第三代二氢吡啶类钙通道阻滞剂,其作用机制与同类药物相似,即可逆地阻滞血管平滑肌细胞膜L型钙通道的钙离子内流,扩张外周血管而降低血压。 | |
【药理作用】盐酸乐卡地平为第三代二氢吡啶类钙通道阻滞剂,其亲脂性较高,起效时间较慢,作用时间较长,血浆达峰时间为2~3h,具有首过代谢的饱和性,食物可增加其吸收,吸收后迅速分布、积聚在细胞膜脂质双层,蛋白结合率高于98%。盐酸乐卡地平主要由CYP3A4代谢,具有广泛的首过效应,无活性代谢产物。50%由粪便排出,44%由尿液排出。 | |
【用途】长效钙拮抗剂-盐酸乐卡地平,其降压疗效肯定,同时具有肾脏保护作用,对血脂也有利。 |
物理化学性质 | |
【熔点 】175-177°C | |
【储存条件 】2-8°C |
安全数据 | |
【危险品标志 】T | |
【危险类别码 】R25 | |
【安全说明 】S36/37-S45 | |
【危险品运输编号 】UN 2811 |
知名试剂公司产品信息 | |
【Sigma Aldrich】132866-11-6(sigmaaldrich) |
盐酸乐卡地平价格(试剂级) | |||||||||||||||||||||
【盐酸乐卡地平价格(试剂级)】
|